New aspects of pain management in acute and chronic inflammatory syndromes

Effective pain control is one of the first and most important challenges in medical practice. Non-steroidal anti-inflammatory drugs (NSAIDs) are the cornerstone of treatment for acute and chronic inflammatory pain syndromes. Of particular interest is a group of patients with a low risk of cardiovasc...

全面介绍

书目详细资料
Main Authors: V. N. Amirdjanova, A. Е. Karateev
格式: 文件
语言:Russian
出版: IMA-PRESS LLC 2021-02-01
丛编:Современная ревматология
主题:
在线阅读:https://mrj.ima-press.net/mrj/article/view/1103
_version_ 1826556859075526656
author V. N. Amirdjanova
A. Е. Karateev
author_facet V. N. Amirdjanova
A. Е. Karateev
author_sort V. N. Amirdjanova
collection DOAJ
description Effective pain control is one of the first and most important challenges in medical practice. Non-steroidal anti-inflammatory drugs (NSAIDs) are the cornerstone of treatment for acute and chronic inflammatory pain syndromes. Of particular interest is a group of patients with a low risk of cardiovascular development and a low to moderate risk of gastrointestinal complications, for whom any NSAID may be recommended. Their choice may depend on the duration and severity of the inflammatory process. The most high analgesic potential have non-selective inhibitors of cyclooxygenase – diclofenac and ketoprofen. Modern technologies give great opportunities for modifying the active substance of NSAIDs and improvement of the drug dosage form in order to hasten their effects and enhance analgesic and anti-inflammatory effect of drugs. In the new form of diclofenac (Dialrapid sachet), sodium salt was replaced by potassium salt, which provided a high rate of both absorption of the active substance and action, comparable to that with intramuscular administration of the drug. It also expanded the possibilities of its use for acute pain and relapses of pain relief in exacerbation of chronic inflammatory diseases. The inclusion of lysine salt significantly changed the pharmacodynamics of ketoprofen. Unlike conventional ketoprofen, its lysine salts (Artrozilen and OKИ) are fast-dissolving compounds with neutral pH that do not irritate the mucous membrane of the gastrointestinal tract, which makes them suitable for long-term treatment of chronic inflammatory pain syndromes.
first_indexed 2024-04-10T02:06:40Z
format Article
id doaj.art-b3fd09e6d27e49fc8bf3dcdcd80c99de
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2025-03-14T08:19:23Z
publishDate 2021-02-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-b3fd09e6d27e49fc8bf3dcdcd80c99de2025-03-02T13:11:04ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2021-02-01151737810.14412/1996-7012-2021-1-73-782326New aspects of pain management in acute and chronic inflammatory syndromesV. N. Amirdjanova0A. Е. Karateev1V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyEffective pain control is one of the first and most important challenges in medical practice. Non-steroidal anti-inflammatory drugs (NSAIDs) are the cornerstone of treatment for acute and chronic inflammatory pain syndromes. Of particular interest is a group of patients with a low risk of cardiovascular development and a low to moderate risk of gastrointestinal complications, for whom any NSAID may be recommended. Their choice may depend on the duration and severity of the inflammatory process. The most high analgesic potential have non-selective inhibitors of cyclooxygenase – diclofenac and ketoprofen. Modern technologies give great opportunities for modifying the active substance of NSAIDs and improvement of the drug dosage form in order to hasten their effects and enhance analgesic and anti-inflammatory effect of drugs. In the new form of diclofenac (Dialrapid sachet), sodium salt was replaced by potassium salt, which provided a high rate of both absorption of the active substance and action, comparable to that with intramuscular administration of the drug. It also expanded the possibilities of its use for acute pain and relapses of pain relief in exacerbation of chronic inflammatory diseases. The inclusion of lysine salt significantly changed the pharmacodynamics of ketoprofen. Unlike conventional ketoprofen, its lysine salts (Artrozilen and OKИ) are fast-dissolving compounds with neutral pH that do not irritate the mucous membrane of the gastrointestinal tract, which makes them suitable for long-term treatment of chronic inflammatory pain syndromes.https://mrj.ima-press.net/mrj/article/view/1103non-steroidal anti-inflammatory drugs (nsaids)dialrapidartrozilen and okи
spellingShingle V. N. Amirdjanova
A. Е. Karateev
New aspects of pain management in acute and chronic inflammatory syndromes
Современная ревматология
non-steroidal anti-inflammatory drugs (nsaids)
dialrapid
artrozilen and okи
title New aspects of pain management in acute and chronic inflammatory syndromes
title_full New aspects of pain management in acute and chronic inflammatory syndromes
title_fullStr New aspects of pain management in acute and chronic inflammatory syndromes
title_full_unstemmed New aspects of pain management in acute and chronic inflammatory syndromes
title_short New aspects of pain management in acute and chronic inflammatory syndromes
title_sort new aspects of pain management in acute and chronic inflammatory syndromes
topic non-steroidal anti-inflammatory drugs (nsaids)
dialrapid
artrozilen and okи
url https://mrj.ima-press.net/mrj/article/view/1103
work_keys_str_mv AT vnamirdjanova newaspectsofpainmanagementinacuteandchronicinflammatorysyndromes
AT aekarateev newaspectsofpainmanagementinacuteandchronicinflammatorysyndromes